Consolidated Statement of Changes in Shareholders' Equity - USD ($)	Total	No Par, Series A Preferred Stock	No Par, Preferred Stock No Par, Series A Preferred Stock	No Par, Common Stock	Retained Earnings (Accumulated deficit)	Accumulated Other Comprehensive Income (Loss)
Balance at beginning of period at Dec. 31, 2022	$ 18,950,000			$ 97,913,000	$ (60,760,000)	$ (18,203,000)
Balance at beginning of period (in shares) at Dec. 31, 2022				12,215,849
Net income (loss)	(25,904,000)				(25,904,000)
Issuance of shares	6,000,000		$ 6,000,000
Issuance of shares (in shares)			1,000
Repurchase of common stock	(3,000)			$ (3,000)
Repurchase of common stock (in shares)				(1,968)
Dividends on Series A preferred stock	(19,000)	$ (19,000)			(19,000)
Stock-based compensation expense	190,000			$ 190,000
Stock-based compensation expense, Shares				9,000
Other comprehensive income (loss)	3,675,000					3,675,000
Balance at end of period at Dec. 31, 2023	2,889,000		$ 6,000,000	$ 98,100,000	(86,683,000)	(14,528,000)
Balance at end of period (in shares) at Dec. 31, 2023			1,000	12,222,881
Net income (loss)	24,347,000				24,347,000
Dividends on Series A preferred stock	(420,000)	(420,000)			(420,000)
Stock-based compensation expense	78,000			$ 78,000
Redemption premium on Series A Preferred Stock	(397,000)	$ (397,000)			(397,000)
Redemption of Series A preferred stock	(6,000,000)		$ (6,000,000)
Redemption of Series A preferred stock, shares			(1,000)
Other comprehensive income (loss)	1,028,000					1,028,000
Balance at end of period at Dec. 31, 2024	$ 21,525,000			$ 98,178,000	$ (63,153,000)	$ (13,500,000)
Balance at end of period (in shares) at Dec. 31, 2024				12,222,881